About TEMTIA The 2011 edition of the International Conference on Epithelial-Mesenchymal Transition (EMT) will be held from 10 – 13 October 2011 in Singapore at Biopolis, hosted by A*STAR - Institute of Molecular and Cell Biology (IMCB). This conference is the 5th biennial meeting for scientists investigating the common and disparate elements of cell phenotypic transitions in development, metastasis, fibrosis and wound healing that result in invasive and/or migratory cells. It is held under the auspices of The Epithelial-Mesenchymal Transition International Association (TEMTIA), an international scientific society organized in Australia at the time of the 1st TEMTIA meeting in 2003. The intent of the meeting is to advance studies of the cellular process of transition by epithelial cells into an invasive cell type (EMT) or its reverse, the formation of an epithelium from fibroblastic or mesenchymal cells (MET). EMT is a cellular process that has engendered much attention as a cellular mechanism that contributes to normal development and may be a cause of congenital birth defects. The formation of three-dimensional structure in the embryo is facilitated by EMT processes including gastrulation, neural crest formation, somite differentiation and heart development, among others. In the adult, EMT is involved in wound healing and in the pathologies of metastasis and fibrosis, which have recently increased the attention to the process. It is clear that an understanding of the process will lead to specific therapeutic treatments for both common and rare diseases. In particular, parallels have been drawn between EMT and cancer stem cells. Scientists from different disciplines who hold different pieces of the puzzle should attend the 5th International EMT Meeting (TEMTIA-V) to enable new insights and approaches in each of the respective research fields to be dynamically interacted and fuelling progress in order to advance health research. |
||||
| Organizing Committee Convenor: Jean Paul Thiery Institute of Molecular and Cell Biology, A*STAR, Singapore Co-Convenor: Erik Thompson St. Vincent’s Institute, Australia |
|
|||
| TEMTIA-V International Committee: Shoukat Dedhar, The BC Cancer Agency Research Centre, Canada David Epstein, OSI Pharmaceuticals, USA Raghu Kalluri, Beth Israel Deaconess Medical Center, USA Angela Nieto, Instituto de Neurociencias (CSIC-UMH), Spain Donald Newgreen, The Murdoch Childrens Research Institute, Australia Raymond Runyan, University of Arizona, USA Pierre Savagner, Institut de Recherche en Cancérologie de Montpellier, France Guojun Sheng, RIKEN Center for Developmental Biology, Japan Jean Paul Thiery, Institute of Molecular and Cell Biology, A*STAR, Singapore Erik Thompson, St. Vincent’s Institute, Australia Alice Wong, The University of Hong Kong, Hong Kong Hongquan Zhang, Beijing Medical University, China Local Organizing Committee: Jean Paul Thiery, Institute of Molecular and Cell Biology, A*STAR, Singapore David Virshup, Duke-NUS Graduate Medical School, Singapore Seiichi Mori, Cancer Science Institute of Singapore, Singapore |
||||
About Organizers |
||||
 Download conference poster (PDF) |
||||
| Hosted by: |
 |
|||
